The global western blotting market is estimated at USD 2.01 billion in 2024 and is expected to grow to USD 2.13 billion in 2025 to reach approximately USD 3.6 billion by 2034, growing at a steady CAGR of 6.05% between 2025 and 2034.
The Complete Study is Now Available for Immediate Access | Download the Sample Pages of this Report @ https://www.towardshealthcare.com/download-sample/5768
The western blotting market is experiencing expansion due to many contributing factors, such as the growing prevalence of chronic disease, including HIV/AIDS, neurological disorders, and cancer, alongside rising funding is boosting the adoption of western blotting approaches. Moreover, breakthroughs in automation, imaging, and detection technologies are increasingly improving the accuracy and effectiveness of Western blotting techniques.
The Western Blotting Market: Highlights
• The Western blotting sector is pushing the market to USD 2.01 billion in 2024.
• Long-term projections show a USD 3.6 billion valuation by 2034.
• Growth is expected at a steady CAGR of 6.05% between 2025 to 2034.
• North America was dominant in the market share by 48% in 2024.
• Asia-Pacific is expected to grow fastest during the forecast period.
• By product, the consumables segment led the western blotting market in 2024.
• By product, the instruments segment is expected to witness significant expansion in the coming years.
• By application, the biomedical & biochemical research segment held a major revenue share of the market in 2024.
• By application, the disease diagnostics segment is expected to be the fastest-growing during 2025-2034.
• By end-use, the academic & research institute segment dominated the western blotting market in 2024.
• By end-use, the diagnostic centers segment is expected to register rapid growth during the forecast period.
Market Overview: Aim at Enhancement of Speed, Sensitivity & Throughput
Primarily, western blotting is also referred to as immunoblotting, is a highly employed laboratory technique for detecting certain proteins in a sample. As per research, immense research and development activities in the biotechnology and pharmaceutical sectors, and advancements in diagnostic technologies are driving the global western blotting market. In 2025, the market will have an accelerated focus on its speed, sensitivity, and throughput, as well as improving reproducibility and allowing single-cell analysis. Thus, Capillary Westerns are used to overcome the transfer step, are gaining traction as a streamlined and robust method for protein analysis.
Report Scope
|
Metric |
Details |
|
Market Size in 2025 |
USD 2.13 Billion |
|
Projected Market Size in 2034 |
USD 3.6 Billion |
|
CAGR (2025 - 2034) |
6.05% |
|
Leading Region |
North America share by 48% |
|
Market Segmentation |
By Product, By Application, By End-Use, By Region |
|
Top Key Players |
Bio-Rad Laboratories, Bio-Techne Corporation, Boster Bio, Cell Culture Company, Creative Proteomics, Cytiva Life Sciences, GE Healthcare, Ichor Life Sciences, Inc., Proteintech Group, Sarepta Therapeutics, Thermo Fisher Scientific, Zyagen |
You can place an order or ask any questions, please feel free to contact us at sales@towardshealthcare.com
Stepping Towards Automation and Digitalization: Major Potential
Currently, the world’s crucial population is aiming at the adoption of automation and digital approaches in various sectors. Inclusion of automated western blotting is becoming highly significant for high-throughput analysis, and reducing manual error is assisting the overall global western blotting market. Along with this, the adoption of digital imaging and machine learning is also being combined to boost data analysis and interpretation, which ultimately helps in progressing the digitalization area. The coming era will encompass a combination of this technique with other sophisticated techniques like MS.
Competitive Threat and Stringent Protocols: Major Challenge
Emergence of advanced techniques like ELISA and mass spectrometry enables quick, more quantitative results, imposing competitive difficulties to Western blotting, especially in high-throughput applications. However, the need for procedural effectiveness propels stricter adherence to protocols and acceleration of different parameters, including sample preparation and antibody selection.
The Western Blotting Market: Regional Analysis
Across the world, North America held the biggest revenue share of 48% in the market in 2024. Due to the highest demand for western blotting, as well as advances in automation and multiplexing techniques are fueling this region’s market growth is being fueled. Also, other incorporated factors are a rise in method validation approaches for antibodies and tracking disease biomarkers in numerous biopharmaceutical companies of North America.
On the other hand, the US is experiencing crucial expansion in the global western blotting market. Growing research funding, investments in proteomics research, and the accelerating focus on personalized medicine are propelling this region's market growth. Along with this, the US has incorporated this technique in research labs and also used it in clinical diagnostics for several applications, like infectious disease diagnosis (e.g., Lyme disease, HIV) and autoimmune disorders.
For instance,
• In July 2025, Creative Biogene, one of the leading biotechnology products and services providers, launched its host cell protein assay kits to ensure scientists' satisfaction in a timely and professional manner.
Canada's well-established academic and medical research infrastructure, mainly in Ontario and British Columbia, offers the adoption of blotting systems in clinical studies and research.
Become a valued research partner with us - https://www.towardshealthcare.com/schedule-meeting
The Asia Pacific is Anticipated to Witness Rapid Expansion During 2025-2034
In the future, the Asia Pacific will grow rapidly in the western blotting market. Countries in ASAP, like China, South Korea, Japan, and India, are experiencing the highest growth due to escalating awareness of advanced diagnostics and enhanced globalization of clinical trials. This results in increased adoption of western blotting approaches. Moreover, the ASAP’s market fosters advances in automation, AI-driven antibody validation, and the development of non-animal-based antibodies.
For instance,
• In June 2025, Genmab announced strategies for late-stage trials of the antibody-drug conjugate Rina-S following promising clinical data.
Japan’s major economic regions, such as Tokyo, Osaka, and Nagoya, are heavily investing in groundbreaking healthcare. Alongside, enhanced emphasis on high-sensitivity ECL (Enhanced Chemiluminescence) western blotting substrates is broadly used in Japan, primarily in biomedical research and proteomics in the western blotting market.
For this market,
• In January 2025, BioMed X, an independent biomedical research institute based in Heidelberg, Germany, collaborated with Daiichi Sankyo Co., a global pharmaceutical company headquartered in Japan, to advance multi-functional biologics in cancer therapy.
On the other hand, in South Korea, ongoing advancements in proteomics technologies, allied with the need for high-throughput protein evaluation, are further boosting the adoption of Western blotting methods.
Get the latest insights on life science industry segmentation with our Annual Membership: https://www.towardshealthcare.com/get-an-annual-membership
The Western Blotting Market: Segmentation Analysis
By product analysis
The consumables segment held the largest revenue share of the market in 2024. Widespread adoption of western blotting approaches in different diseases is fueling the adoption of diverse consumables. They mainly comprise a variety of reagents and buffers for sample preparation, electrophoresis, and transfer. Besides this, pre-packaged kits consisting of all essential reagents and materials for specific western blotting applications are also accessible.
Although the instruments segment is predicted to grow notably in the studied years, drivers, like growing biomedical research and disease diagnosis, are propelling the utilization of highly sophisticated instruments. They mainly encompass gel electrophoresis for protein separation, blotting systems, such as wet and semi-dry blotting approaches. Along with this, western blotting imagers, like chemiluminescent imagers and fluorescent imagers, are used to identify and quantify proteins on the membrane.
By application analysis
In the global western blotting market, the biomedical & biochemical research segment led in 2024. The presence of well-equipped laboratories and other biotechnology firms facilitates the broad use of Western blotting. In biomedical research, this blotting plays a major role in protein analysis, molecular biology, and studying disease pathophysiology. Furthermore, western blotting comprises protein-protein interactions, protein-DNA interactions, post-translational changes, and disease diagnosis.
The disease diagnostics segment will grow at a rapid CAGR in the predicted period. Across the market, diverse techniques are employed, especially for ensuring outcomes from initial screening tests like ELISA. Also, they are certainly applied for the detection of specific proteins or antibodies associated with diseases like HIV, Lyme disease, and various autoimmune disorders. However, the segment is expanded by diagnosing conditions like Bovine Spongiform Encephalopathy (BSE) and Feline Immunodeficiency Virus (FIV).
By end-use analysis
In 2024, the academic & research institute segment was dominant in the western blotting market. The segment is driven by public funding, an efficient tradition of using Western blotting in academic and research settings, and the need for precise and reproducible protein analysis. In addition, academic institutions prefer western blotting for training purposes, further expanding its market reach.
However, the diagnostic centers segment is estimated to witness rapid expansion during 2025-2034. As a rise in chronic condition cases, along with immense advances in automation, imaging, and detection chemistries, accelerates the sensitivity, accuracy, and efficiency of western blotting, making it more attractive for diagnostic applications. Enhanced expenditure on research and development, combined with the progression of diagnostic laboratories and healthcare facilities, propels the adoption of Western blotting techniques.
Browse More Insights of Towards Healthcare:
The global cell culture market is valued at USD 20.61 billion in 2024 and is expected to grow to USD 22.95 billion in 2025. Looking ahead, the market is projected to reach approximately USD 60.38 billion by 2034, expanding at a CAGR of 11.35% over the forecast period.
The CRISPR market is anticipated to rise from USD 2.94 billion in 2024 to USD 3.27 billion in 2025, with further growth expected to surpass USD 8.58 billion by 2034, reflecting a steady CAGR of 11.24%.
The plasmid DNA manufacturing market was valued at USD 1.85 billion in 2023 and is projected to reach USD 12.27 billion by 2034, growing at a robust CAGR of 18.77% between 2024 and 2034.
The animal biotechnology market is estimated at USD 28.17 billion in 2024 and is forecast to increase to USD 30.97 billion in 2025. By 2034, the market is expected to touch USD 72.6 billion, expanding at a CAGR of 9.93% between 2025 and 2034.
Driven by innovations in precision medicine, AI-enabled drug development, and a growing pipeline of targeted therapies, the oncology drug discovery market is poised for significant growth between 2024 and 2034.
The synthetic biology market is projected to surge from USD 16.39 billion in 2023 to an impressive USD 191.48 billion by 2034, growing at an annual rate of 25.04% from 2024 onward.
The next-generation sequencing market is valued at USD 10.27 billion in 2024, growing to USD 12.51 billion in 2025, and is expected to reach around USD 73.47 billion by 2034, expanding at a CAGR of 21.74%.
The cell line development market stands at USD 5.86 billion in 2024 and is projected to grow to USD 6.44 billion in 2025. By 2034, the market is expected to reach USD 14.92 billion, growing at a CAGR of 9.85% over the forecast period.
The DNA sequencing market was valued at USD 12.42 billion in 2023 and is anticipated to grow to USD 107.63 billion by 2034, reflecting a CAGR of 21.69% from 2024 onwards.
The DNA read, write, and edit market is estimated at USD 7.35 billion in 2024, rising to USD 8.35 billion in 2025, and is projected to reach USD 26.46 billion by 2034, expanding at a CAGR of 13.63%.
Western Blotting Market Companies:
• Bio-Rad Laboratories
• Bio-Techne Corporation
• Boster Bio
• Cell Culture Company
• Creative Proteomics
• Cytiva Life Sciences
• GE Healthcare
• Ichor Life Sciences, Inc.
• Proteintech Group
• Sarepta Therapeutics
• Thermo Fisher Scientific
• Zyagen
Ongoing Developments in the Market
|
Company |
Recent Updates |
|
Kling Bio (July 2025) |
Made a collaboration and license option agreement with Sanofi for the discovery of antibodies and epitopes using its B cell immortalisation and screening platform, Kling-Select. |
|
Agilus Diagnostics (July 2025) |
Launched a new Anti-MCV antibody test for the early diagnosis of rheumatoid arthritis |
|
LigaChem Biosciences (June 2025) |
Launched two new cancer target antibodies from the U.S. partner |
|
Invenra (April 2025) |
Introduced B-Body Express™ Service, which allows faster access to its premier B-Body® Bispecific antibody platform |
|
Simcere Zaiming (January 2025) |
Partnered with AbbVie Inc. to develop SIM0500, an investigational new drug candidate. |
What are the Latest Developments in the Western Blotting Market?
• In April 2025, Elix and PRISM BioLab collaborated to boost AI-driven drug Discovery for challenging protein-protein interaction targets.
• In February 2025, Bio-Rad Laboratories, Inc., a global life science research and clinical diagnostics products company, introduced its TrailBlazer Tag and TrailBlazer StarBright Dye Label Kits.
• In July 2024, Bio-Rad Laboratories, Inc., launched the ChemiDoc Go Imaging System, the latest expansion to its portfolio of ChemiDoc Imaging Systems, to allow faster, reliable, and highly sensitive gel and western blot imaging on a benchtop scale.
Western Blotting Market Segmentation
By Product
• Consumers
• Reagents
• Kits
• Instruments
• Gel Electrophoresis
• Blotting Systems
• Semi-Dry Blotting Instruments
• Wet Blotting Instruments
• Imagers
• Chemiluminescent Imagers
• Fluorescent Imagers
• Others
By Application
• Biomedical & Biochemical Research
• Disease Diagnostics
• Agriculture
• Others
By End-Use
• Academic & Research Institutes
• Pharmaceutical & Biotechnology Companies
• Diagnostic Centers
• Others
By Region
• North America
• U.S.
• Canada
• Asia Pacific
• China
• Japan
• India
• South Korea
• Thailand
• Europe
• Germany
• UK
• France
• Italy
• Spain
• Sweden
• Denmark
• Norway
• Latin America
• Brazil
• Mexico
• Argentina
• Middle East and Africa (MEA)
• South Africa
• UAE
• Saudi Arabia
• Kuwait
Immediate Delivery Available | Buy This Premium Research @ https://www.towardshealthcare.com/price/5768
Access our exclusive, data-rich dashboard dedicated to the healthcare market - built specifically for decision-makers, strategists, and industry leaders. The dashboard features comprehensive statistical data, segment-wise market breakdowns, regional performance shares, detailed company profiles, annual updates, and much more. From market sizing to competitive intelligence, this powerful tool is one-stop solution to your gateway.
Access the Dashboard: https://www.towardshealthcare.com/access-dashboard
Become a valued research partner with us - https://www.towardshealthcare.com/schedule-meeting
About Us
Towards Healthcare is a leading global provider of technological solutions, clinical research services, and advanced analytics, with a strong emphasis on life science research. Dedicated to advancing innovation in the life sciences sector, we build strategic partnerships that generate actionable insights and transformative breakthroughs. As a global strategy consulting firm, we empower life science leaders to gain a competitive edge, drive research excellence, and accelerate sustainable growth.
You can place an order or ask any questions, please feel free to contact us at sales@towardshealthcare.com
Europe Region: +44 778 256 0738
North America Region: +1 8044 4193 44
APAC Region: +91 9356 9282 04
Web: https://www.towardshealthcare.com
Find us on social platforms: LinkedIn | Twitter | Instagram | Medium | Pinterest
